Geschäftskunden Kundenprogramme

KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb
Produktbild: The Resistance of Cervical Cancer to Chemotherapy and Its Reversal

The Resistance of Cervical Cancer to Chemotherapy and Its Reversal Volume 9

Aus der Reihe Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy

Fr. 201.00

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

The Resistance of Cervical Cancer to Chemotherapy and its Reversal provides a holistic understanding of cervical cancer development, immune-evading mechanisms of HPV, immunotherapies available, methods to study cervical cancer and the development of newer drugs. Content shows the involvement of signaling...

Beschreibung

The Resistance of Cervical Cancer to Chemotherapy and its Reversal provides a holistic understanding of cervical cancer development, immune-evading mechanisms of HPV, immunotherapies available, methods to study cervical cancer and the development of newer drugs. Content shows the involvement of signaling pathways during chemoresistance in cervical cancer, the involvement of genes in drug resistance, and introduces long noncoding RNAs as novel biomarkers.
In 10 chapters, this book first provides an introduction and history of cervical cancer; next, it discusses the influence of viruses on cervical cancer and finally, it describes therapies to overcome chemotherapy resistance in cervical cancer. This is the perfect reference to provide the fundamental base of knowledge needed for oncologists, pharmacologists, translational investigators, immunotherapists, scientists, and clinicians interested in building a comprehensive understanding of the field.

Portrait

Dr. Sridhar Muthusami completed his Ph.D in endocrinology in the year 2011 from the University of Madras, India. His doctoral study was aimed at delineating the molecular mechanism underlying the anabolic actions of Cissus quadrangularis, an indigenous herb believed to exert anabolic effects on bone cells through IGFR. After completing his Ph.D, he has joined for his Postdoctoral work in the department of Radiation Oncology, Chungbuk National University, South Korea. He has worked on the role of Epidermal growth factor/receptor (EGF/EGFR) signaling and its regulation of oncoprotein Fused Toes Homolog (FTS) in cervical cancer cells from 2011 to 2014. He is also involved in the identifying the role of T0070907/EGCG/cordycepin on cervical cancer cells. Since 2015, he moved to the department of biochemistry, Karpagam Academy of Higher Education (Deemed to be University) and serving as Associate Professor and Head at Cancer Research Centre working in the area of development of EGFR TKIs for the treatment/management of cervical cancer/pancreatic cancer.

Produktdetails

Einband

Gebundene Ausgabe
Erscheinungsdatum

20.03.2026
Herausgeber S. Muthusami
Verlag Elsevier Science & Technology

Produktdetails

Einband

Gebundene Ausgabe
Erscheinungsdatum

20.03.2026
Herausgeber S. Muthusami
Verlag Elsevier Science & Technology
Seitenzahl

364
Maße (L/B/H)

23.8/19/2.4 cm
Gewicht

862 g
Sprache

Englisch
ISBN

978-0-443-22352-5
EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com
Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: The Resistance of Cervical Cancer to Chemotherapy and Its Reversal

    1. Role of Wnt/ß¿catenin signaling pathway in cervical cancer: Strategies to overcome therapeutic resistance
    2. Targeting epigenetic regulatory machinery to overcome cervical cancer chemoresistance
    3. The role of immune checkpoint proteins PD1 and PD¿L1 during cancer resistance
    4. Advancements in radiotherapy: transforming cervical cancer treatment
    5. Pathogenesis of human papillomavirus induced carcinogenesis: insights on in vivo models and prophylactic strategies
    6. Subcellular transport of epidermal growth factor receptor: diverse approaches in targeting epidermal growth factor receptor¿driven cervical carcinoma
    7. Structural insights into Human papillomavirus E6 and E7 oncoproteins: implications for drug design and therapeutic targeting
    8. Critical insights to understand the underlying mechanisms in cervical cancer metastasis
    9. Advancements of cytology in cervical cancer
    10. Insights on molecular mechanisms of chemoresistance in cervical cancer
    11. Computational techniques to study the cervical cancer
    12. Advances in nanotechnology¿based drug development and delivery for cervical cancer therapeutic strategies